When Does Sharing Make Sense?: Antitrust & Risk Evaluation and Mitigation Strategies

CPI Antitrust Chronicle, Vol. 4, No. 2, April 2014

7 Pages Posted: 1 May 2014  

Jan M. Rybnicek

Freshfields Bruckhaus Deringer LLP

Date Written: April 29, 2014

Abstract

There exists a new front in the battle to define the circumstances under which a monopolist’s refusal to deal with a rival constitutes exclusionary conduct that violates Section 2 of the Sherman Act. The latest clash arises in the context of a brand-name drug manufacturer’s decision not to sell samples of a patented drug that is subject to certain government-mandated restricted distribution protocols to a potential generic rival seeking to use those samples to conduct bioequivalence testing necessary to develop a generic version of the product. Without access to these samples, the generic firm may be unable to sell a generic version of the drug to consumers at a significantly lower price than the branded product. Against the compelling backdrop of a health care system afflicted by rapidly rising costs, some now argue that the antitrust laws should be used to force brand-name drug companies to share samples of their products with generic rivals to further competition and reduce the cost of prescription drugs. Although ambiguity remains about the exact contours of “refusal-to-deal” law in the United States, it is unlikely for several reasons that this potential problem can or should be remedied through the blunt instrument of the antitrust laws.

Keywords: Antitrust, Competition, Risk Evaluation and Mitigation Strategies, REMS, Refusal to Deal, Trinko, Aspen Skiing, Hatch-Waxman

Suggested Citation

Rybnicek, Jan M., When Does Sharing Make Sense?: Antitrust & Risk Evaluation and Mitigation Strategies (April 29, 2014). CPI Antitrust Chronicle, Vol. 4, No. 2, April 2014. Available at SSRN: https://ssrn.com/abstract=2429330

Jan M. Rybnicek (Contact Author)

Freshfields Bruckhaus Deringer LLP

700 13th St NW
Floor 10
Washington, DC 20005
United States

Paper statistics

Downloads
93
Rank
229,523
Abstract Views
605